 Barclays PLC trimmed its position in shares of PDL BioPharma Inc NASDAQ:PDLI by 57.8 during the fourth quarter, HoldingsChannel reports. The firm owned 114,927 shares of the biotechnology companys stock after selling 157,472 shares during the quarter. Barclays PLCs holdings in PDL BioPharma were worth 372,000 at the end of the most recent quarter. Other ... 